Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eduardo Couchonnal Bedoya"'
Autor:
Olivier Guillaud, Alain Lachaux, Justin Mbala, Abdelouahed Belmalih, Eduardo Couchonnal Bedoya
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Introduction Wilson’s disease (WD) is a copper metabolism disorder characterised by a progressive accumulation of this metal mainly in the liver and the brain. Treatment is based on the removal of copper operated by the chelators, among which, D-pe
Externí odkaz:
https://doaj.org/article/a4f75c2e3d9448a49fc9da5ad472a786
Autor:
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, David Cassiman, Carlos Twardowschy, Aurelia Poujois, Francisco de Assis A Gondim, Gerald Denk, Rubens G Cury, Peter Ott, Joanna Moore, Aftab Ala, Renata D'Inca, Eduardo Couchonnal-Bedoya, Koenraad D'Hollander, Nicolas Dubois, C Omar F Kamlin, Karl Heinz Weiss, Uyen To, Amar Patel, Daksshi Hettiarachchi, Alessia Giorgini, Sara Monico, Tomasz Litwin, Agnieszka Piechal, Marta Skowronska, Alain Lachaux, Abdelouahed Belmalih, Alexandra Boogers, Isabelle Mohr, Andrea Langel, Christian Freitas, Egberto Reis Barbosa, Thomas D Sandahl, Lisbet Gerdes, Alexandre Obadia, Djamila Rahli, Jeremy Cosgrove
Publikováno v:
CHELATE trial investigators 2022, ' Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE) : a randomised, open-label, non-inferiority, phase 3 trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 12, pp. 1092-1102 . https://doi.org/10.1016/S2468-1253(22)00270-9
Background: Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-establish copper balance, trientine is indicated for patients with penicillamine intolerance. We aimed to compare penicillami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc08a6d996987fd1d2dba0c63b14f359
https://pure.au.dk/portal/da/publications/trientine-tetrahydrochloride-versus-penicillamine-for-maintenance-therapy-in-wilson-disease-chelate(ba317b8b-40a9-4b06-9881-6e93f059c2ea).html
https://pure.au.dk/portal/da/publications/trientine-tetrahydrochloride-versus-penicillamine-for-maintenance-therapy-in-wilson-disease-chelate(ba317b8b-40a9-4b06-9881-6e93f059c2ea).html
Publikováno v:
Diagnostics. 13:256
Wilson disease and alpha1-antitrypsin deficiency are two rare genetic diseases that may impact predominantly the liver and/or the brain, and the liver and/or the lung, respectively. The early diagnosis of these diseases is important in order to initi
Autor:
Guillaume Petit, Paul Jaulent, Eduardo Couchonnal-Bedoya, Olivier Guillaud, Stéphane Thobois, Chloé Laurencin
Publikováno v:
Revue neurologique. 178(4)
Autor:
Muriel Bost, Vincent Balter, Laurence Lion-François, Abdelouahed Belmalih, Olivier Guillaud, Aline Lamboux, Elisabeth Mintz, Alain Lachaux, Chloé Laurencin, Eduardo Couchonnal-Bedoya, Virginie Brun
Publikováno v:
Metallomics
Metallomics, Royal Society of Chemistry, 2020, 12 (11), pp.1781-1790. ⟨10.1039/d0mt00167h⟩
Metallomics, 2020, 12 (11), pp.1781-1790. ⟨10.1039/d0mt00167h⟩
Metallomics, Royal Society of Chemistry, 2020, 12 (11), pp.1781-1790. ⟨10.1039/d0mt00167h⟩
Metallomics, 2020, 12 (11), pp.1781-1790. ⟨10.1039/d0mt00167h⟩
Wilson disease (WD) is an autosomal recessive disorder of copper (Cu) metabolism. The gene responsible for WD, ATP7B, is involved in the cellular transport of Cu, and mutations in the ATP7B gene induce accumulation of Cu in the liver and ultimately i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db48ea39519c215c1f861b4537f3286
https://hal.archives-ouvertes.fr/hal-03044206
https://hal.archives-ouvertes.fr/hal-03044206
Autor:
Peter Ott, Thomas Sandahl, Aftab Ala, David Cassiman, Eduardo Couchonnal-Bedoya, Rubens Gisbert Cury, Anna Czlonkowska, Gerald Denk, Renata D’Inca, Francisco de Assis Aquino Gondim, Joanna Moore, Aurelia Poujois, Carlos Alexandre Twardowschy, Karl Heinz Weiss, Massimo Zuin, C.Omar F. Kamlin, Michael L. Schilsky
Publikováno v:
JHEP Reports, Vol 6, Iss 8, Pp 101115- (2024)
Background & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges of urinary copper excretion (UCE) of
Externí odkaz:
https://doaj.org/article/90b27145c7244d369bafae9917758cfd